

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 5.34982785 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91759328 |
| 3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.81635970 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.58109382 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54402776 |
| 6 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.46251288 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.42284410 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.42284410 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38387157 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38387157 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.38387157 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38387157 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.38387157 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38387157 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.27997381 |
| 16 | positive regulation of protein deacetylation (GO:0090312) | 4.08578474 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.98045538 |
| 18 | detection of bacterium (GO:0016045) | 3.91878299 |
| 19 | detection of other organism (GO:0098543) | 3.87673080 |
| 20 | negative regulation of cell size (GO:0045792) | 3.87463258 |
| 21 | response to peptidoglycan (GO:0032494) | 3.86748531 |
| 22 | modulation by virus of host process (GO:0019054) | 3.79686837 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.77886483 |
| 24 | response to muramyl dipeptide (GO:0032495) | 3.73440421 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.69477971 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.59654254 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.58854824 |
| 28 | megakaryocyte development (GO:0035855) | 3.55330338 |
| 29 | leukocyte aggregation (GO:0070486) | 3.53999750 |
| 30 | modulation by symbiont of host cellular process (GO:0044068) | 3.52518480 |
| 31 | sarcomere organization (GO:0045214) | 3.52124581 |
| 32 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.48405186 |
| 33 | regulation of erythrocyte differentiation (GO:0045646) | 3.40745762 |
| 34 | natural killer cell differentiation (GO:0001779) | 3.37557915 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.36227624 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33108392 |
| 37 | tolerance induction (GO:0002507) | 3.29963144 |
| 38 | germinal center formation (GO:0002467) | 3.28115771 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.26754258 |
| 40 | response to type I interferon (GO:0034340) | 3.22897697 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.22591910 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.22591910 |
| 43 | platelet formation (GO:0030220) | 3.17010181 |
| 44 | cardiac myofibril assembly (GO:0055003) | 3.16870000 |
| 45 | thymic T cell selection (GO:0045061) | 3.16429486 |
| 46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15859389 |
| 47 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.15453875 |
| 48 | negative regulation of stress fiber assembly (GO:0051497) | 3.15053833 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.14812139 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.14812139 |
| 51 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.14601849 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.09344890 |
| 53 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.08325318 |
| 54 | cellular response to virus (GO:0098586) | 3.04260239 |
| 55 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.02092303 |
| 56 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.01935163 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.01054598 |
| 58 | response to host immune response (GO:0052572) | 3.01054598 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01000076 |
| 60 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.99773995 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98926796 |
| 62 | response to host (GO:0075136) | 2.98926796 |
| 63 | response to host defenses (GO:0052200) | 2.98926796 |
| 64 | nucleosome disassembly (GO:0006337) | 2.97384978 |
| 65 | protein-DNA complex disassembly (GO:0032986) | 2.97384978 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 2.97094488 |
| 67 | maternal placenta development (GO:0001893) | 2.96114874 |
| 68 | apoptotic process involved in morphogenesis (GO:0060561) | 2.96002709 |
| 69 | regulation of leukocyte degranulation (GO:0043300) | 2.95837915 |
| 70 | cellular response to zinc ion (GO:0071294) | 2.94308218 |
| 71 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.94077152 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.91347604 |
| 73 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91290420 |
| 74 | embryonic hemopoiesis (GO:0035162) | 2.91248612 |
| 75 | pre-miRNA processing (GO:0031054) | 2.90091891 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.89963836 |
| 77 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89827687 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88529341 |
| 79 | negative regulation of viral release from host cell (GO:1902187) | 2.88434343 |
| 80 | negative regulation of histone methylation (GO:0031061) | 2.86512498 |
| 81 | positive regulation of lamellipodium organization (GO:1902745) | 2.86077835 |
| 82 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.85817807 |
| 83 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.83886518 |
| 84 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.82645081 |
| 85 | regulation of translational fidelity (GO:0006450) | 2.79432067 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.78208078 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 2.78066199 |
| 88 | myofibril assembly (GO:0030239) | 2.77396256 |
| 89 | neutrophil activation (GO:0042119) | 2.77076002 |
| 90 | mannose metabolic process (GO:0006013) | 2.76989451 |
| 91 | positive regulation of lamellipodium assembly (GO:0010592) | 2.76928002 |
| 92 | negative regulation of granulocyte differentiation (GO:0030853) | 2.76763225 |
| 93 | cell-substrate adherens junction assembly (GO:0007045) | 2.76060346 |
| 94 | focal adhesion assembly (GO:0048041) | 2.76060346 |
| 95 | regulation of histone deacetylation (GO:0031063) | 2.75918318 |
| 96 | NLS-bearing protein import into nucleus (GO:0006607) | 2.75807892 |
| 97 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.75535145 |
| 98 | trophectodermal cell differentiation (GO:0001829) | 2.73628368 |
| 99 | negative regulation of innate immune response (GO:0045824) | 2.73446353 |
| 100 | negative thymic T cell selection (GO:0045060) | 2.73402069 |
| 101 | detection of biotic stimulus (GO:0009595) | 2.70778786 |
| 102 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.70611169 |
| 103 | erythrocyte development (GO:0048821) | 2.69814466 |
| 104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69779604 |
| 105 | T cell selection (GO:0045058) | 2.69403129 |
| 106 | histone H3-K36 demethylation (GO:0070544) | 2.69392483 |
| 107 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.69037838 |
| 108 | dosage compensation (GO:0007549) | 2.67823513 |
| 109 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.66954331 |
| 110 | T cell apoptotic process (GO:0070231) | 2.66865899 |
| 111 | response to interleukin-15 (GO:0070672) | 2.66405405 |
| 112 | regulation of integrin activation (GO:0033623) | 2.66187268 |
| 113 | negative regulation of type 2 immune response (GO:0002829) | 2.65397072 |
| 114 | granulocyte activation (GO:0036230) | 2.64984611 |
| 115 | negative T cell selection (GO:0043383) | 2.64963630 |
| 116 | retinoic acid receptor signaling pathway (GO:0048384) | 2.64561765 |
| 117 | positive T cell selection (GO:0043368) | 2.62240124 |
| 118 | plasma membrane repair (GO:0001778) | 2.62230785 |
| 119 | RNA stabilization (GO:0043489) | 2.61694857 |
| 120 | mRNA stabilization (GO:0048255) | 2.61694857 |
| 121 | histone H4-K16 acetylation (GO:0043984) | 2.60779587 |
| 122 | regulation of T cell tolerance induction (GO:0002664) | 2.59732022 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.56697494 |
| 124 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56076412 |
| 125 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.55341500 |
| 126 | respiratory burst (GO:0045730) | 2.53866712 |
| 127 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.52962415 |
| 128 | negative regulation of T cell mediated immunity (GO:0002710) | 2.52775011 |
| 129 | regulation of tolerance induction (GO:0002643) | 2.51549926 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.51489084 |
| 131 | B cell homeostasis (GO:0001782) | 2.51221829 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 2.50774449 |
| 133 | mitotic G1/S transition checkpoint (GO:0044819) | 2.50578184 |
| 134 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.49914435 |
| 135 | cardiac muscle contraction (GO:0060048) | 2.49627218 |
| 136 | negative regulation of necroptotic process (GO:0060546) | 2.48947013 |
| 137 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.47756572 |
| 138 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46963387 |
| 139 | regulation of chromatin binding (GO:0035561) | 2.44983656 |
| 140 | peptidyl-lysine dimethylation (GO:0018027) | 2.44474861 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 2.44427221 |
| 142 | defense response to protozoan (GO:0042832) | 2.43264220 |
| 143 | negative regulation of interleukin-12 production (GO:0032695) | 2.43157723 |
| 144 | adherens junction assembly (GO:0034333) | 2.43155649 |
| 145 | regulation of necroptotic process (GO:0060544) | 2.42891177 |
| 146 | T cell migration (GO:0072678) | 2.42509382 |
| 147 | regulation of type 2 immune response (GO:0002828) | 2.42295629 |
| 148 | myeloid cell development (GO:0061515) | 2.41823139 |
| 149 | negative regulation of RNA splicing (GO:0033119) | 2.41416413 |
| 150 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.41389017 |
| 151 | Peyers patch development (GO:0048541) | 2.41389017 |
| 152 | cell-substrate junction assembly (GO:0007044) | 2.41332029 |
| 153 | execution phase of apoptosis (GO:0097194) | 2.41190799 |
| 154 | regulation of protein deacetylation (GO:0090311) | 2.40966235 |
| 155 | positive regulation of type 2 immune response (GO:0002830) | 2.40483792 |
| 156 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.40335736 |
| 157 | myeloid cell activation involved in immune response (GO:0002275) | 2.40214696 |
| 158 | signal complex assembly (GO:0007172) | 2.39792305 |
| 159 | response to protozoan (GO:0001562) | 2.39444547 |
| 160 | sodium ion export (GO:0071436) | 2.39362153 |
| 161 | modulation by virus of host morphology or physiology (GO:0019048) | 2.39320886 |
| 162 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.39223868 |
| 163 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.37321740 |
| 164 | activation of JUN kinase activity (GO:0007257) | 2.36612237 |
| 165 | barbed-end actin filament capping (GO:0051016) | 2.35810385 |
| 166 | positive regulation of RNA splicing (GO:0033120) | 2.35063130 |
| 167 | stress fiber assembly (GO:0043149) | 2.32218205 |
| 168 | response to laminar fluid shear stress (GO:0034616) | 2.31730258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MYC_22102868_ChIP-Seq_BL_Human | 4.01882827 |
| 2 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.17518766 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71866211 |
| 4 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.64890529 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62077333 |
| 6 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.52905264 |
| 7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.51916039 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36464636 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.36371839 |
| 10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24721211 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24060678 |
| 12 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22475517 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19566160 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16928016 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.16518223 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.07856123 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06304908 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02791048 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99441408 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94583842 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92531802 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91127171 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86212071 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81868010 |
| 25 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.79892057 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72349860 |
| 27 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.71337543 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71173707 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68856528 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62729608 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.60247193 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58219264 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57749312 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55691645 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53678941 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53388466 |
| 37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.53039138 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.50983811 |
| 39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50479378 |
| 40 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49887319 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.48874065 |
| 42 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47683390 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47143097 |
| 44 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43205515 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42538541 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41468020 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41160386 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40496568 |
| 49 | * MYB_26560356_Chip-Seq_TH1_Human | 1.40432585 |
| 50 | * MYB_26560356_Chip-Seq_TH2_Human | 1.37140869 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35389122 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35154559 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32762324 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32611361 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30431210 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30415686 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29830854 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29820166 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29560895 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28618285 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28063468 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27150954 |
| 63 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.24990877 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24154434 |
| 65 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23883019 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23868116 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23739193 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23228229 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22686282 |
| 70 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22539173 |
| 71 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21072131 |
| 72 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20993296 |
| 73 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19584461 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19524062 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19350261 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18294574 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17547457 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17185366 |
| 79 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.16556355 |
| 80 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16470933 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16465750 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16458144 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16049063 |
| 84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15723183 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15259950 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14299478 |
| 87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14012333 |
| 88 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13824447 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13773602 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12351517 |
| 91 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.12318106 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12019977 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11499420 |
| 94 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10387180 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10226855 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08144929 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07940995 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07693374 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06420649 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06288307 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06216726 |
| 102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06188162 |
| 103 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05733020 |
| 104 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05227806 |
| 105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03622371 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03431060 |
| 107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02364027 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01945542 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01932086 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01790100 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01577370 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01391185 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00712334 |
| 114 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00710907 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00350430 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99964887 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99467387 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98901012 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98901012 |
| 120 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98886835 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98500099 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98498987 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98235889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.20851575 |
| 2 | MP0005451_abnormal_body_composition | 3.12066883 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.69506071 |
| 4 | MP0003646_muscle_fatigue | 2.67370454 |
| 5 | MP0008260_abnormal_autophagy | 2.54199094 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.39561782 |
| 7 | MP0003724_increased_susceptibility_to | 2.35374379 |
| 8 | MP0004510_myositis | 2.30966321 |
| 9 | MP0003303_peritoneal_inflammation | 2.24815745 |
| 10 | MP0000685_abnormal_immune_system | 2.23518218 |
| 11 | MP0001545_abnormal_hematopoietic_system | 2.18378735 |
| 12 | MP0005397_hematopoietic_system_phenotyp | 2.18378735 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.17155079 |
| 14 | MP0008961_abnormal_basal_metabolism | 2.15770915 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.11981491 |
| 16 | MP0000751_myopathy | 2.10028215 |
| 17 | MP0004808_abnormal_hematopoietic_stem | 2.09479740 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.03264036 |
| 19 | MP0003436_decreased_susceptibility_to | 2.02469951 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 1.93948502 |
| 21 | MP0002398_abnormal_bone_marrow | 1.86817366 |
| 22 | MP0009785_altered_susceptibility_to | 1.84240907 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.83289528 |
| 24 | MP0004087_abnormal_muscle_fiber | 1.77993928 |
| 25 | MP0001800_abnormal_humoral_immune | 1.75953150 |
| 26 | MP0000749_muscle_degeneration | 1.74272941 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.73933423 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.69212061 |
| 29 | MP0010630_abnormal_cardiac_muscle | 1.69163093 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.68452600 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.65892570 |
| 32 | MP0002269_muscular_atrophy | 1.63661839 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.62827651 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.62747429 |
| 35 | MP0000858_altered_metastatic_potential | 1.61800982 |
| 36 | MP0009840_abnormal_foam_cell | 1.61607529 |
| 37 | MP0004381_abnormal_hair_follicle | 1.61550272 |
| 38 | MP0001790_abnormal_immune_system | 1.60962798 |
| 39 | MP0005387_immune_system_phenotype | 1.60962798 |
| 40 | MP0002132_abnormal_respiratory_system | 1.59052796 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.56270764 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.55476747 |
| 43 | MP0004130_abnormal_muscle_cell | 1.54223874 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.53942175 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.51874019 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.51102842 |
| 47 | MP0002722_abnormal_immune_system | 1.51092684 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.45797867 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.45768042 |
| 50 | MP0000716_abnormal_immune_system | 1.45760945 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.44720410 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.43918466 |
| 53 | MP0003828_pulmonary_edema | 1.42475187 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.41133605 |
| 55 | MP0004858_abnormal_nervous_system | 1.40428391 |
| 56 | MP0001849_ear_inflammation | 1.39336135 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.39283841 |
| 58 | MP0001819_abnormal_immune_cell | 1.38183894 |
| 59 | MP0002405_respiratory_system_inflammati | 1.37072675 |
| 60 | MP0002429_abnormal_blood_cell | 1.35788024 |
| 61 | MP0005330_cardiomyopathy | 1.33888797 |
| 62 | MP0000759_abnormal_skeletal_muscle | 1.32996013 |
| 63 | MP0002723_abnormal_immune_serum | 1.32977069 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.32567969 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.30659857 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.29304099 |
| 67 | MP0004233_abnormal_muscle_weight | 1.23821812 |
| 68 | MP0000747_muscle_weakness | 1.22704910 |
| 69 | MP0005671_abnormal_response_to | 1.20548114 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.20480344 |
| 71 | MP0006082_CNS_inflammation | 1.19644250 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.17904911 |
| 73 | MP0001873_stomach_inflammation | 1.17157102 |
| 74 | MP0000733_abnormal_muscle_development | 1.16467332 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.14515012 |
| 76 | MP0003866_abnormal_defecation | 1.14508457 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.14353439 |
| 78 | MP0004947_skin_inflammation | 1.14138969 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.12835267 |
| 80 | MP0005025_abnormal_response_to | 1.12490311 |
| 81 | MP0008775_abnormal_heart_ventricle | 1.11813713 |
| 82 | MP0005666_abnormal_adipose_tissue | 1.09974131 |
| 83 | MP0001853_heart_inflammation | 1.09817388 |
| 84 | MP0008469_abnormal_protein_level | 1.06633644 |
| 85 | MP0000266_abnormal_heart_morphology | 1.05604302 |
| 86 | MP0000490_abnormal_crypts_of | 1.03647838 |
| 87 | MP0005023_abnormal_wound_healing | 1.03319628 |
| 88 | MP0005375_adipose_tissue_phenotype | 1.02999583 |
| 89 | MP0002249_abnormal_larynx_morphology | 1.02743493 |
| 90 | MP0005670_abnormal_white_adipose | 1.01798294 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 1.00433177 |
| 92 | MP0005369_muscle_phenotype | 0.99056853 |
| 93 | MP0005310_abnormal_salivary_gland | 0.98232284 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 0.98182430 |
| 95 | MP0005385_cardiovascular_system_phenoty | 0.98182430 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.97890502 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.96781678 |
| 98 | MP0003984_embryonic_growth_retardation | 0.96147732 |
| 99 | MP0002088_abnormal_embryonic_growth/wei | 0.94592444 |
| 100 | MP0002796_impaired_skin_barrier | 0.94048394 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.93570726 |
| 102 | MP0005409_darkened_coat_color | 0.93468662 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.93317800 |
| 104 | MP0003279_aneurysm | 0.89785310 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89647862 |
| 106 | MP0000343_altered_response_to | 0.88770777 |
| 107 | MP0002925_abnormal_cardiovascular_devel | 0.88678271 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.88647177 |
| 109 | MP0002419_abnormal_innate_immunity | 0.88608869 |
| 110 | MP0001851_eye_inflammation | 0.87640308 |
| 111 | MP0005390_skeleton_phenotype | 0.87302011 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.86425099 |
| 113 | MP0009672_abnormal_birth_weight | 0.85606831 |
| 114 | MP0002086_abnormal_extraembryonic_tissu | 0.83035173 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.82667813 |
| 116 | MP0008770_decreased_survivor_rate | 0.81843765 |
| 117 | MP0000313_abnormal_cell_death | 0.80485396 |
| 118 | MP0002909_abnormal_adrenal_gland | 0.78892523 |
| 119 | MP0002970_abnormal_white_adipose | 0.78888794 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.78699474 |
| 121 | MP0001672_abnormal_embryogenesis/_devel | 0.78343460 |
| 122 | MP0005380_embryogenesis_phenotype | 0.78343460 |
| 123 | MP0003077_abnormal_cell_cycle | 0.78336540 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.78031660 |
| 125 | MP0003075_altered_response_to | 0.76752757 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.76557444 |
| 127 | MP0003091_abnormal_cell_migration | 0.76527897 |
| 128 | MP0005501_abnormal_skin_physiology | 0.75262226 |
| 129 | MP0009931_abnormal_skin_appearance | 0.75111018 |
| 130 | MP0002933_joint_inflammation | 0.74872711 |
| 131 | MP0000604_amyloidosis | 0.72177832 |
| 132 | MP0005083_abnormal_biliary_tract | 0.71347199 |
| 133 | MP0005621_abnormal_cell_physiology | 0.71258490 |
| 134 | MP0003329_amyloid_beta_deposits | 0.70386180 |
| 135 | MP0002009_preneoplasia | 0.69341269 |
| 136 | MP0003111_abnormal_nucleus_morphology | 0.67703665 |
| 137 | MP0001730_embryonic_growth_arrest | 0.67612016 |
| 138 | MP0001663_abnormal_digestive_system | 0.64603480 |
| 139 | MP0003448_altered_tumor_morphology | 0.62214285 |
| 140 | MP0008874_decreased_physiological_sensi | 0.61604237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.00392368 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.67395214 |
| 3 | Myositis (HP:0100614) | 3.42232946 |
| 4 | Ventricular tachycardia (HP:0004756) | 3.39812772 |
| 5 | Exercise-induced myalgia (HP:0003738) | 3.39406062 |
| 6 | Hyperacusis (HP:0010780) | 3.26024046 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 3.23772151 |
| 8 | Asymmetric septal hypertrophy (HP:0001670) | 3.16285794 |
| 9 | Polycythemia (HP:0001901) | 3.08834445 |
| 10 | Colitis (HP:0002583) | 3.05539525 |
| 11 | Abnormality of the fingertips (HP:0001211) | 3.04873097 |
| 12 | Cellulitis (HP:0100658) | 3.04386760 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04282621 |
| 14 | Obstructive lung disease (HP:0006536) | 3.04282621 |
| 15 | Nasal polyposis (HP:0100582) | 3.02593194 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 3.01396825 |
| 17 | Orchitis (HP:0100796) | 2.99116543 |
| 18 | Meningitis (HP:0001287) | 2.98305428 |
| 19 | Sudden death (HP:0001699) | 2.96237816 |
| 20 | Cerebral aneurysm (HP:0004944) | 2.95201168 |
| 21 | Exercise-induced muscle cramps (HP:0003710) | 2.90210834 |
| 22 | Difficulty running (HP:0009046) | 2.88364110 |
| 23 | Verrucae (HP:0200043) | 2.87991581 |
| 24 | Papilloma (HP:0012740) | 2.87991581 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 2.83250785 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 2.75709677 |
| 27 | Recurrent viral infections (HP:0004429) | 2.75232496 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 2.74796678 |
| 29 | Difficulty climbing stairs (HP:0003551) | 2.72771755 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71454394 |
| 31 | Increased connective tissue (HP:0009025) | 2.70341671 |
| 32 | Muscle fiber splitting (HP:0003555) | 2.59399767 |
| 33 | Inflammation of the large intestine (HP:0002037) | 2.57671775 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 2.56547062 |
| 35 | Chronic otitis media (HP:0000389) | 2.55299550 |
| 36 | Gingivitis (HP:0000230) | 2.54476040 |
| 37 | Increased density of long bones (HP:0006392) | 2.53353652 |
| 38 | Recurrent skin infections (HP:0001581) | 2.52862217 |
| 39 | Abnormal platelet function (HP:0011869) | 2.51623198 |
| 40 | Impaired platelet aggregation (HP:0003540) | 2.51623198 |
| 41 | Obstructive sleep apnea (HP:0002870) | 2.51226271 |
| 42 | Myoglobinuria (HP:0002913) | 2.48378979 |
| 43 | Subaortic stenosis (HP:0001682) | 2.43994080 |
| 44 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.43994080 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.43825441 |
| 46 | Easy fatigability (HP:0003388) | 2.43789198 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.41447684 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.40178495 |
| 49 | Optic neuritis (HP:0100653) | 2.38776943 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.38776943 |
| 51 | Vasculitis (HP:0002633) | 2.37025565 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.36957513 |
| 53 | Bundle branch block (HP:0011710) | 2.36859537 |
| 54 | Urticaria (HP:0001025) | 2.36637859 |
| 55 | Dysmetric saccades (HP:0000641) | 2.35598981 |
| 56 | Broad face (HP:0000283) | 2.33378502 |
| 57 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32753848 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.32282059 |
| 59 | Hypertensive crisis (HP:0100735) | 2.31035230 |
| 60 | Limb-girdle muscle atrophy (HP:0003797) | 2.30226865 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 2.27395057 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.25379947 |
| 63 | Upper limb amyotrophy (HP:0009129) | 2.25379947 |
| 64 | Myopathic facies (HP:0002058) | 2.25149432 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.25091971 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.22968051 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.22968051 |
| 68 | Frequent falls (HP:0002359) | 2.20702436 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 2.20428665 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.20399148 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.19347421 |
| 72 | Fatigue (HP:0012378) | 2.18918486 |
| 73 | Reticulocytosis (HP:0001923) | 2.17853744 |
| 74 | Loss of speech (HP:0002371) | 2.16157820 |
| 75 | Polygenic inheritance (HP:0010982) | 2.14040286 |
| 76 | Encephalitis (HP:0002383) | 2.12418453 |
| 77 | Hand muscle atrophy (HP:0009130) | 2.12244232 |
| 78 | Metaphyseal cupping (HP:0003021) | 2.10258338 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.10163211 |
| 80 | Stomatitis (HP:0010280) | 2.09357597 |
| 81 | EMG: myopathic abnormalities (HP:0003458) | 2.08707198 |
| 82 | Broad distal phalanx of finger (HP:0009836) | 2.05968219 |
| 83 | EMG: neuropathic changes (HP:0003445) | 2.05182065 |
| 84 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04967894 |
| 85 | Long eyelashes (HP:0000527) | 2.04776676 |
| 86 | Abnormality of the columella (HP:0009929) | 2.03381579 |
| 87 | Abnormality of the thoracic spine (HP:0100711) | 2.02598055 |
| 88 | Petechiae (HP:0000967) | 2.00224477 |
| 89 | Hypochromic anemia (HP:0001931) | 1.99865820 |
| 90 | Long toe (HP:0010511) | 1.99236107 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 1.99146031 |
| 92 | Lymphopenia (HP:0001888) | 1.99010581 |
| 93 | Long palpebral fissure (HP:0000637) | 1.98625065 |
| 94 | Distal lower limb muscle weakness (HP:0009053) | 1.97732621 |
| 95 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97310874 |
| 96 | Chest pain (HP:0100749) | 1.97103250 |
| 97 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96552014 |
| 98 | Broad palm (HP:0001169) | 1.95833191 |
| 99 | Slow saccadic eye movements (HP:0000514) | 1.95329604 |
| 100 | Atrial fibrillation (HP:0005110) | 1.93981267 |
| 101 | Aneurysm (HP:0002617) | 1.91982875 |
| 102 | Thin bony cortex (HP:0002753) | 1.91609022 |
| 103 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91590218 |
| 104 | Bicuspid aortic valve (HP:0001647) | 1.90820086 |
| 105 | Increased cerebral lipofuscin (HP:0011813) | 1.89925300 |
| 106 | Increased IgM level (HP:0003496) | 1.89704411 |
| 107 | Atrioventricular block (HP:0001678) | 1.89668159 |
| 108 | Ulnar bowing (HP:0003031) | 1.88403094 |
| 109 | Macroorchidism (HP:0000053) | 1.88344834 |
| 110 | Increased serum ferritin (HP:0003281) | 1.88024100 |
| 111 | Lipoatrophy (HP:0100578) | 1.87907401 |
| 112 | Abnormality of the lower motor neuron (HP:0002366) | 1.87258066 |
| 113 | Primary atrial arrhythmia (HP:0001692) | 1.86113523 |
| 114 | Ulnar deviation of the wrist (HP:0003049) | 1.86110605 |
| 115 | Axonal loss (HP:0003447) | 1.85141091 |
| 116 | Pustule (HP:0200039) | 1.84855623 |
| 117 | Supraventricular tachycardia (HP:0004755) | 1.84347910 |
| 118 | Large for gestational age (HP:0001520) | 1.83284756 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.81753821 |
| 120 | Heart block (HP:0012722) | 1.81403548 |
| 121 | Supraventricular arrhythmia (HP:0005115) | 1.81263753 |
| 122 | Insomnia (HP:0100785) | 1.80711843 |
| 123 | Sepsis (HP:0100806) | 1.80137987 |
| 124 | Progressive external ophthalmoplegia (HP:0000590) | 1.79927237 |
| 125 | Osteomyelitis (HP:0002754) | 1.79587458 |
| 126 | Calf muscle hypertrophy (HP:0008981) | 1.79197173 |
| 127 | Dislocated radial head (HP:0003083) | 1.77954238 |
| 128 | IgM deficiency (HP:0002850) | 1.77859646 |
| 129 | Rhabdomyolysis (HP:0003201) | 1.77587597 |
| 130 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77166026 |
| 131 | Distal lower limb amyotrophy (HP:0008944) | 1.77125926 |
| 132 | Elfin facies (HP:0004428) | 1.76380658 |
| 133 | Recurrent abscess formation (HP:0002722) | 1.76142416 |
| 134 | Granulocytopenia (HP:0001913) | 1.75882129 |
| 135 | Basal cell carcinoma (HP:0002671) | 1.75800407 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.74962914 |
| 137 | Hypercortisolism (HP:0001578) | 1.74894897 |
| 138 | Purpura (HP:0000979) | 1.74633542 |
| 139 | Emphysema (HP:0002097) | 1.73980278 |
| 140 | Annular pancreas (HP:0001734) | 1.73941953 |
| 141 | Increased IgE level (HP:0003212) | 1.73479195 |
| 142 | Neoplasm of the heart (HP:0100544) | 1.72978715 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.72889267 |
| 144 | Viral hepatitis (HP:0006562) | 1.72360851 |
| 145 | Thrombocytosis (HP:0001894) | 1.71928222 |
| 146 | Keratoconjunctivitis sicca (HP:0001097) | 1.71762237 |
| 147 | Recurrent otitis media (HP:0000403) | 1.71656560 |
| 148 | Epistaxis (HP:0000421) | 1.71237665 |
| 149 | Abnormality of the radial head (HP:0003995) | 1.70757443 |
| 150 | Premature loss of primary teeth (HP:0006323) | 1.70317657 |
| 151 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69595488 |
| 152 | Abnormal atrioventricular conduction (HP:0005150) | 1.69566941 |
| 153 | Right ventricular cardiomyopathy (HP:0011663) | 1.68908388 |
| 154 | Hypertriglyceridemia (HP:0002155) | 1.68016422 |
| 155 | Pointed chin (HP:0000307) | 1.67956235 |
| 156 | Dilated cardiomyopathy (HP:0001644) | 1.67670363 |
| 157 | Depressed nasal tip (HP:0000437) | 1.67605536 |
| 158 | Restrictive lung disease (HP:0002091) | 1.67505643 |
| 159 | Prominent nose (HP:0000448) | 1.65956031 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.65951955 |
| 161 | Disproportionate tall stature (HP:0001519) | 1.65381189 |
| 162 | Increased variability in muscle fiber diameter (HP:0003557) | 1.64629065 |
| 163 | Abnormality of T cells (HP:0002843) | 1.64624093 |
| 164 | Late onset (HP:0003584) | 1.64253354 |
| 165 | Myotonia (HP:0002486) | 1.64106453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.20269158 |
| 2 | TRIB3 | 4.17408342 |
| 3 | EEF2K | 3.66342461 |
| 4 | ERN1 | 3.55979862 |
| 5 | MAP4K1 | 3.41962271 |
| 6 | PRPF4B | 3.39396653 |
| 7 | SMG1 | 3.17482894 |
| 8 | CDK12 | 3.08970764 |
| 9 | PKN2 | 2.77368592 |
| 10 | TTN | 2.57068473 |
| 11 | RIPK4 | 2.46132950 |
| 12 | ICK | 2.01785478 |
| 13 | IRAK4 | 1.97012280 |
| 14 | TAOK1 | 1.92657022 |
| 15 | SIK2 | 1.80932561 |
| 16 | IRAK3 | 1.69433462 |
| 17 | BLK | 1.64186861 |
| 18 | DMPK | 1.58814071 |
| 19 | STK10 | 1.54637473 |
| 20 | MAP2K3 | 1.51496436 |
| 21 | TESK2 | 1.51466897 |
| 22 | PRKD3 | 1.50403590 |
| 23 | RIPK1 | 1.48598377 |
| 24 | MAPKAPK3 | 1.42834927 |
| 25 | TNK2 | 1.42279587 |
| 26 | SIK1 | 1.39399406 |
| 27 | PTK6 | 1.37438979 |
| 28 | TYK2 | 1.37168107 |
| 29 | MAP3K14 | 1.32053970 |
| 30 | MAP3K3 | 1.30320439 |
| 31 | MAP3K7 | 1.30194995 |
| 32 | TGFBR2 | 1.27293599 |
| 33 | PRKD2 | 1.25971009 |
| 34 | ZAP70 | 1.25156150 |
| 35 | FES | 1.24941779 |
| 36 | GRK6 | 1.21790225 |
| 37 | LRRK2 | 1.17301680 |
| 38 | MAP3K11 | 1.09699621 |
| 39 | CSF1R | 1.07502319 |
| 40 | BTK | 1.06594510 |
| 41 | JAK3 | 1.06582748 |
| 42 | ALK | 1.03010357 |
| 43 | IRAK2 | 1.00297158 |
| 44 | RPS6KA4 | 1.00007915 |
| 45 | NEK2 | 0.98960639 |
| 46 | HIPK2 | 0.98820396 |
| 47 | BMX | 0.98590748 |
| 48 | MTOR | 0.95722754 |
| 49 | NME2 | 0.94016703 |
| 50 | CAMK1G | 0.93648047 |
| 51 | HCK | 0.92501725 |
| 52 | CAMK1D | 0.90859322 |
| 53 | CDK4 | 0.90356122 |
| 54 | TBK1 | 0.86762710 |
| 55 | SIK3 | 0.86068042 |
| 56 | RPS6KB2 | 0.85394195 |
| 57 | MARK2 | 0.81799304 |
| 58 | EPHB1 | 0.81475229 |
| 59 | SYK | 0.81234048 |
| 60 | KIT | 0.80514079 |
| 61 | MAP2K2 | 0.80478612 |
| 62 | PRKCH | 0.77720921 |
| 63 | PDPK1 | 0.76285412 |
| 64 | DYRK1B | 0.76174440 |
| 65 | PHKG1 | 0.75796252 |
| 66 | PHKG2 | 0.75796252 |
| 67 | FGFR4 | 0.75718573 |
| 68 | DYRK3 | 0.75532083 |
| 69 | JAK1 | 0.74536239 |
| 70 | RPS6KA6 | 0.72591855 |
| 71 | PIM1 | 0.71824996 |
| 72 | NEK1 | 0.71202026 |
| 73 | TESK1 | 0.70895339 |
| 74 | RPS6KC1 | 0.70886834 |
| 75 | RPS6KL1 | 0.70886834 |
| 76 | CAMK4 | 0.68519556 |
| 77 | JAK2 | 0.68023349 |
| 78 | EPHA2 | 0.67917089 |
| 79 | TAOK2 | 0.67911043 |
| 80 | KSR2 | 0.67417063 |
| 81 | FGR | 0.67379422 |
| 82 | PRKD1 | 0.66173596 |
| 83 | CSK | 0.65952217 |
| 84 | MAPK12 | 0.65838767 |
| 85 | ITK | 0.64824375 |
| 86 | PAK4 | 0.64682535 |
| 87 | RPS6KA2 | 0.61052413 |
| 88 | MAPK11 | 0.60904577 |
| 89 | LYN | 0.60399992 |
| 90 | MAPK7 | 0.60000852 |
| 91 | TYRO3 | 0.59220797 |
| 92 | CDK19 | 0.57506156 |
| 93 | MATK | 0.56478819 |
| 94 | PDGFRA | 0.56201855 |
| 95 | MAP3K1 | 0.55509132 |
| 96 | PDK1 | 0.55459756 |
| 97 | CLK1 | 0.55382274 |
| 98 | IKBKB | 0.54922657 |
| 99 | MAP3K8 | 0.53493379 |
| 100 | MAPK15 | 0.52738557 |
| 101 | CHUK | 0.51988046 |
| 102 | SGK3 | 0.51103847 |
| 103 | MAPKAPK2 | 0.51096870 |
| 104 | STK4 | 0.50240776 |
| 105 | MAP3K13 | 0.49237228 |
| 106 | CDK6 | 0.48728013 |
| 107 | ARAF | 0.48206534 |
| 108 | TAOK3 | 0.48058547 |
| 109 | CDK7 | 0.47887900 |
| 110 | CDK9 | 0.47720636 |
| 111 | MARK3 | 0.47584265 |
| 112 | MELK | 0.46172466 |
| 113 | RPS6KA1 | 0.46131737 |
| 114 | LMTK2 | 0.46063123 |
| 115 | CDC42BPA | 0.43529740 |
| 116 | BRD4 | 0.43037504 |
| 117 | PRKAA1 | 0.42559419 |
| 118 | LCK | 0.42222769 |
| 119 | ILK | 0.41461279 |
| 120 | STK38 | 0.41218394 |
| 121 | RAF1 | 0.40875675 |
| 122 | CAMK1 | 0.39661317 |
| 123 | MAP3K6 | 0.39082384 |
| 124 | RET | 0.38540929 |
| 125 | KDR | 0.38324087 |
| 126 | PIM2 | 0.38152767 |
| 127 | IKBKE | 0.38027658 |
| 128 | PRKG2 | 0.37868201 |
| 129 | IRAK1 | 0.32670967 |
| 130 | BCKDK | 0.31472586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42514246 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.28912365 |
| 3 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.16009865 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.10768097 |
| 5 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.89448262 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87664894 |
| 7 | Lysine degradation_Homo sapiens_hsa00310 | 1.85838412 |
| 8 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.66052818 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64341960 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.60958828 |
| 11 | Insulin resistance_Homo sapiens_hsa04931 | 1.56831915 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.56740165 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.54151752 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53578609 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50151316 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49710634 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49522007 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48209229 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48167468 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46789079 |
| 21 | Hepatitis C_Homo sapiens_hsa05160 | 1.45722420 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44632016 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43077188 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41369329 |
| 25 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.39609955 |
| 26 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.38960120 |
| 27 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.37345690 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33944529 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31842611 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.29551797 |
| 31 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.28182916 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28100422 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27883725 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27568091 |
| 35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.27197498 |
| 36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.23916693 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19470052 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.18475386 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.14948263 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14709387 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14205699 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.14101127 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12690394 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11310177 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.11278662 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 1.11172516 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11072500 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.10496522 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.10262202 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.08797431 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.06222256 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05518450 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03596138 |
| 54 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.03194606 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03006192 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02965854 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02543594 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01038975 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.00617358 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00268051 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99798758 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98715137 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95462524 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95082812 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95069298 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93100877 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.92098717 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91299052 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89906171 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89753119 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89732146 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.87998949 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.87847324 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85104191 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84253037 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.83943348 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83624438 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82579343 |
| 79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82362423 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.81710796 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81272164 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80022133 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.78298013 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77876767 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77148908 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76917034 |
| 87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76527204 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75007083 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74776344 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73942810 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.73602929 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73300648 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72455517 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71682765 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70701668 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70578667 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.70278348 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.69487194 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.69362923 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68084052 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65760380 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65270936 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64724452 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63566523 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63231377 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62762197 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.62623727 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61693627 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61494992 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61396599 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60966665 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59879590 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59864020 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59788654 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58158771 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57940116 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57935596 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56446310 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.56009335 |
| 120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55898020 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55724070 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54599465 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.54566240 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52421097 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51002695 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.50553188 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.50489423 |

